Hedge Fund - Solas Capital Management
Fennec Pharmaceuticals Inc. (FENC)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $15,466,916 | 9.6% | 1,378,513 | $8.28 |
| 2 | 2023 - Q3 (2023-09-30) | $12,959,008 | 9.06% | 1,725,567 | $8.14 |
| 3 | 2023 - Q2 (2023-06-30) | $12,706,617 | 8.45% | 1,439,028 | $8.31 |
| 4 | 2023 - Q1 (2023-03-31) | $10,687,398 | 5.7% | 1,284,543 | $9.27 |
| 5 | 2022 - Q4 (2022-12-31) | $12,022,925 | 7.21% | 1,252,388 | $8.85 |
| 6 | 2022 - Q3 (2022-09-30) | $9,162,000 | 5.58% | 1,131,167 | $6.86 |
| 7 | 2022 - Q2 (2022-06-30) | $6,548,000 | 3.9% | 1,173,516 | $5.80 |
| 8 | 2022 - Q1 (2022-03-31) | $6,416,000 | 3.88% | 1,145,796 | $5.04 |
| 9 | 2021 - Q4 (2021-12-31) | $3,819,000 | 2.72% | 867,857 | $7.44 |
| 10 | 2021 - Q3 (2021-09-30) | $8,175,000 | 5.68% | 867,857 | $7.50 |
| 11 | 2021 - Q2 (2021-06-30) | $6,327,000 | 4.43% | 867,857 | $6.67 |
| 12 | 2021 - Q1 (2021-03-31) | $4,968,000 | 4.17% | 800,000 | $7.53 |
| 13 | 2020 - Q4 (2020-12-31) | $5,960,000 | 4.54% | 800,000 | $7.62 |
| 14 | 2020 - Q3 (2020-09-30) | $4,848,000 | 4.64% | 800,000 | $7.05 |
| 15 | 2020 - Q2 (2020-06-30) | $8,016,000 | 7.39% | 960,000 | $7.44 |
| 16 | 2020 - Q1 (2020-03-31) | $5,702,000 | 6.17% | 960,000 | $6.52 |
| 17 | 2019 - Q4 (2019-12-31) | $6,307,000 | 6.06% | 971,795 | $5.37 |
| 18 | 2019 - Q3 (2019-09-30) | $4,537,000 | 4.69% | 943,200 | $4.41 |
| 19 | 2019 - Q2 (2019-06-30) | $3,400,000 | 3.47% | 849,979 | $4.23 |
The displayed share prices are average quarterly stock market prices.